All ExchangesCASI Pharmaceuticals Stock Signals
Latest Data & Signals Issued
| Signal Type | Signal Value | Data | |
|---|---|---|---|
| Score | -5.148 | 7 days ( 5.56 % ) | |
| Last Price | $2.04 | -0.97 % | |
| High/ Low | $2.03 - $2.11 | 0.488% | |
| Chg 7 Days | -2.86 % | $2.10 $2.04 | |
| Chg 30 Days | -9.33 % | $2.25 $2.04 | |
| Chg 12 mos | -44.11 % | $3.65 $2.04 | |
| Trend - 3 mos | -21.47 % | Width: 19.74 % | |
| Trend - 12 mos | 12.83 % | Width: 116.23 % | |
| Pred. range - 3 mos | $1.51 - $1.81 | -25.75 % - -11.09 % | |
| Pred. range - 12 mos | $2.04 - $4.40 | -0.186 % - 115.82 % | |
| Short mv avg 3 mos | Sell | 2023-08-28 - 17 days | |
| Long mv avg 3 mos | Buy | 2023-08-23 - 20 days | |
| Short/Long mv avg 3 mos | Sell | 2023-07-26 - 40 days | |
| Short mv avg 12 mos | Sell | 2023-08-28 - 17 days | |
| Long mv avg 12 mos | Sell | 2023-07-25 - 41 days | |
| Short/Long mv avg 12 mos | Sell | 2023-08-07 - 32 days | |
| Pivot Short | Sell | 2023-08-24 - 19 days | |
| Bollinger | Buy | 2023-09-01 - 13 days | |
| MACD | Sell | No Dates Stored For This Signal |
Signals Effectiveness
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
Stock Score
Bollinger Bands
MACD
Moving Average (7d)
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
